Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma
Clinical trial NCT07371923 · RECRUITING
Trial details
- NCT number
- NCT07371923
- Sponsor
- Beijing Tongren Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-20
- Primary completion
- 2028-02-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.